
Astrana Health (ASTH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
620.4M
Gross Profit
71.3M
11.50%
Operating Income
20.6M
3.32%
Net Income
6.2M
1.00%
EPS (Diluted)
$0.14
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
813.6M
Shareholders Equity
517.7M
Debt to Equity
1.57
Cash Flow Metrics
Operating Cash Flow
12.7M
Free Cash Flow
13.6M
Revenue & Profitability Trend
Astrana Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.0B | 1.4B | 1.1B | 773.9M | 370.2M |
Cost of Goods Sold | 1.8B | 1.2B | 944.7M | 596.1M | 348.5M |
Gross Profit | 271.4M | 215.0M | 199.5M | 177.8M | 21.7M |
Gross Margin % | 13.3% | 15.5% | 17.4% | 23.0% | 5.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 154.1M | 112.6M | 77.7M | 62.1M | 15.6M |
Other Operating Expenses | - | - | -6.2M | -6.5M | -5.0M |
Total Operating Expenses | 154.1M | 112.6M | 71.5M | 55.5M | 10.6M |
Operating Income | 89.4M | 84.6M | 104.3M | 98.2M | 6.1M |
Operating Margin % | 4.4% | 6.1% | 9.1% | 12.7% | 1.6% |
Non-Operating Items | |||||
Interest Income | 14.5M | 14.2M | 2.0M | 1.6M | 405.0K |
Interest Expense | 33.1M | 16.1M | 7.9M | 5.4M | 2.5M |
Other Non-Operating Income | 10.1M | 7.1M | -11.7M | -16.6M | 4.9M |
Pre-tax Income | 80.8M | 89.8M | 86.6M | 77.7M | 8.9M |
Income Tax | 30.9M | 32.0M | 40.9M | 31.7M | 9.2M |
Effective Tax Rate % | 38.2% | 35.6% | 47.2% | 40.8% | 103.5% |
Net Income | 49.9M | 57.8M | 45.7M | 46.1M | -314.0K |
Net Margin % | 2.5% | 4.2% | 4.0% | 6.0% | -0.1% |
Key Metrics | |||||
EBITDA | 141.1M | 128.3M | 133.4M | 109.2M | 40.3M |
EPS (Basic) | $0.91 | $1.30 | $1.09 | $1.69 | $1.04 |
EPS (Diluted) | $0.90 | $1.29 | $1.08 | $1.63 | $1.01 |
Basic Shares Outstanding | 47597295 | 46705385 | 44999083 | 43702959 | 36409615 |
Diluted Shares Outstanding | 47597295 | 46705385 | 44999083 | 43702959 | 36409615 |
Income Statement Trend
Astrana Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 288.5M | 293.8M | 288.0M | 233.1M | 193.5M |
Short-term Investments | 2.4M | 2.5M | 5.6M | 53.4M | 67.7M |
Accounts Receivable | 225.7M | 76.8M | 49.6M | 10.6M | 7.1M |
Inventory | - | - | - | - | - |
Other Current Assets | 22.9M | 17.4M | 14.8M | 18.6M | 16.8M |
Total Current Assets | 638.5M | 461.5M | 428.1M | 404.5M | 338.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 32.6M | 37.4M | 20.4M | 15.4M | 18.6M |
Goodwill | 956.7M | 629.3M | 615.0M | 575.6M | 565.1M |
Intangible Assets | 118.2M | 71.6M | 76.9M | 82.8M | 87.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 32.6M | 18.2M | 20.5M | 21.9M | 19.4M |
Total Non-Current Assets | 716.4M | 471.9M | 538.1M | 462.9M | 478.9M |
Total Assets | 1.4B | 933.4M | 966.2M | 867.4M | 817.5M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 15.2M | 9.1M | 10.5M | 5.5M | 9.6M |
Short-term Debt | 15.3M | 24.8M | 4.8M | 3.9M | 14.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 235.3M | 125.6M | 81.3M | 55.8M | 50.3M |
Total Current Liabilities | 365.6M | 218.7M | 148.6M | 114.7M | 115.0M |
Non-Current Liabilities | |||||
Long-term Debt | 456.6M | 296.3M | 224.6M | 197.1M | 246.4M |
Deferred Tax Liabilities | 4.6M | 4.1M | 14.2M | 30.1M | 11.0M |
Other Non-Current Liabilities | 14.0M | 3.6M | 20.3M | 14.8M | - |
Total Non-Current Liabilities | 475.1M | 303.9M | 259.1M | 242.0M | 257.3M |
Total Liabilities | 840.7M | 522.6M | 407.7M | 356.7M | 372.3M |
Equity | |||||
Common Stock | 48.0K | 47.0K | 47.0K | 45.0K | 42.0K |
Retained Earnings | 286.3M | 243.1M | 182.4M | 137.2M | 69.8M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 514.2M | 410.8M | 558.5M | 510.6M | 445.1M |
Key Metrics | |||||
Total Debt | 471.8M | 321.0M | 229.4M | 201.0M | 260.6M |
Working Capital | 272.9M | 242.8M | 279.5M | 289.7M | 223.6M |
Balance Sheet Composition
Astrana Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 49.9M | 57.8M | 45.7M | 46.1M | 122.1M |
Depreciation & Amortization | 27.9M | 17.7M | 17.5M | 17.5M | 18.4M |
Stock-Based Compensation | 34.5M | 22.0M | 16.1M | 6.7M | 3.4M |
Working Capital Changes | -52.8M | -20.4M | -2.8M | -36.3M | 10.5M |
Operating Cash Flow | 70.6M | 73.4M | 67.0M | 46.0M | 156.0M |
Investing Activities | |||||
Capital Expenditures | -8.0M | -28.5M | -22.9M | -19.2M | -1.1M |
Acquisitions | -156.1M | -7.5M | -18.5M | -3.9M | 31.4M |
Investment Purchases | -2.6M | -6.2M | -1.9M | -28.0M | -1.8M |
Investment Sales | 124.0K | 491.0K | 31.7M | 67.6M | 50.6M |
Investing Cash Flow | -192.4M | -65.5M | -7.5M | 16.5M | 95.5M |
Financing Activities | |||||
Share Repurchases | -937.0K | -10.2M | -9.2M | -5.7M | -537.0K |
Dividends Paid | -4.0M | -62.1M | -14.0M | -31.1M | -51.3M |
Debt Issuance | 171.9M | 284.5M | 3.6M | 180.6M | 0 |
Debt Repayment | -19.2M | -205.4M | -4.4M | -238.5M | -9.6M |
Financing Cash Flow | 134.1M | 1.9M | -28.7M | 123.2M | -62.5M |
Free Cash Flow | 44.2M | 39.7M | 59.2M | 51.1M | 45.0M |
Net Change in Cash | 12.4M | 9.8M | 30.8M | 185.8M | 189.0M |
Cash Flow Trend
Astrana Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
56.49
Forward P/E
19.57
Price to Book
1.92
Price to Sales
0.57
PEG Ratio
-1.08
Profitability Ratios
Profit Margin
1.04%
Operating Margin
3.11%
Return on Equity
5.44%
Return on Assets
3.25%
Financial Health
Current Ratio
1.59
Debt to Equity
83.20
Beta
0.86
Per Share Data
EPS (TTM)
$0.53
Book Value per Share
$15.58
Revenue per Share
$50.09
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
asth | 1.4B | 56.49 | 1.92 | 5.44% | 1.04% | 83.20 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 2.0B | 14.09 | 0.63 | 4.83% | 4.31% | 74.74 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.